Ranok is a privately held, clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics. Ranok was founded by a leadership team of industry veterans from both Chinese and American biotech and pharmaceutical companies and is based in two of the world’s leading centers of innovation and medical research: Hangzhou, China and Boston, Massachusetts USA. By bringing together the cutting edges of medical research from both China and the United States, our goal is to create transformative medicines for patients suffering from cancer and other serious diseases. Ranok has been chased by the top tier Investors all the time, we have closed A round, B round and B+ round fund raising in 2019, 2021 and 2023.
For more information, please follow us at LinkedIn and Twitter @RanokTx.
Media & Investor Contact:
Ms. Xiaoyan Qiu
Ranok Therapeutics
Ranok Therapeutics
United States
303 Wyman Street, Suite 300
Waltham, MA 02451
China
Floor 4, Building 16
Hexiang Science and Technology Center
Qiantang District, Hangzhou 310020
0571-86630936
© 2023 Ranok Therapeutics Co. Ltd.
